Tag Archives: EC

February, 2016

  • 3 February

    AstraZeneca’s Tagrisso Wins European Approval for Treatment of Lung Cancer

    AstraZeneca today announced that the European Commission (EC) has granted conditional marketing authorisation for TAGRISSO™ (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Osimertinib is indicated for patients with T790M …

January, 2016

  • 19 January

    Biogen-Samsung’s Enbrel Biosimilar Wins European Approval

    ZUG, Switzerland–(BUSINESS WIRE)–The joint venture between Biogen (NASDAQ:BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an etanercept biosimilar referencing Enbrel®i. BENEPALI has been granted marketing authorization in the European Union (EU) for the treatment of adults with moderate to severe rheumatoid arthritis …

April, 2015

  • 3 April

    AbbVie’s Humira Approved for Childhood Psoriasis in Europe

    AbbVie’s Humira has been approved by European health regulators for use in children with psoriasis. The European Commission (EC) has granted marketing authorization for AbbVie’s Humira (adalimumab) for the treatment of severe chronic plaque psoriasis in children and adolescents from four years of age who have had an inadequate response …